Veracyte's Thyroid Cancer MDx Gets New York State OK
August 29, 2012
Veracyte's Thyroid Cancer MDx Gets New York State OK
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- UnitedHealthcare Starting Coverage of Veractye's Thyroid Cancer MDx
March 8, 2013 / GenomeWeb Daily News - New York Approves Exagen Lupus Test
October 25, 2012 / GenomeWeb Daily News - Prospective Validation Confirms Sensitivity of Veracyte's Gene Expression Test for Thyroid Nodule Risk
June 27, 2012 / Pharmacogenomics Reporter - Enzo Files for Approval from New York for First AmpiProbe Assay
March 13, 2012 / GenomeWeb Daily News - Enzo Gets NY State OK to Sell GeneNews Test
February 21, 2012 / GenomeWeb Daily News